Kenneth Breslauer, born in 1947[1] in Jönköping, Sweden, is the Linus C. Pauling Distinguished Professor of Chemistry and Chemical Biology at Rutgers University.
[4] The database and its extensions also have been used to design probes and drugs with predictable hybridization and binding properties, a capability key to various diagnostic and therapeutic protocols.
[6] He also serves on numerous scientific advisory boards, including those associated with the Cancer Institute of New Jersey,[7] the Center for Advanced Biotechnology and Medicine,[8] as well as federal funding agency study sections.
And a broad range of Core Facilities (confocal microscopy, high-field NMR, Mass Spectrometry, Calorimetry and Spectroscopy, Imaging, etc.).
[10] As Vice President for health science partnerships, Breslauer has assumed a leadership role in establishing with the University of Medicine and Dentistry of New Jersey the Stem Cell Institute of New Jersey, the Center for Clinical Translational Sciences, Shared Major Instrumentation Research Facilities, as well as partnerships with universities in China, Taiwan, Africa, and elsewhere, including mutually beneficial cooperative agreements with the private sector.
Although he started college as a history major, Kenneth Breslauer graduated in 1968 with honors from the University of Wisconsin, with both a bachelor's degree in chemistry as well as a B.A.
As a postdoc at the University of California at Berkeley, Breslauer investigated and characterized the molecular forces associated with dictating and controlling nucleic acid stability.
At Rutgers since 1974, he combines these fields by investigating protein-DNA, and drug-DNA interactions, particularly as they relate to regulation of gene expression, DNA damage repair, and molecular diseases.